SCHEMBL6272841

SCHEMBL6272841

COc1ccc(-c2nc(C(N)=O)oc2-c2ccc(OCCNC(=O)O)cc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 3/20 0.43
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
RCE1 Q9Y256 1/20 0.39
CNR1 P21554 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
CDK2 P24941 1/20 0.37
GSK3B P49841 1/20 0.37
HDAC6 Q9UBN7 2/20 0.37
SCN9A Q15858 1/20 0.36
APP P05067 1/20 0.36
NNMT P40261 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539809 0.88 CA12 (0.46) PPARDMKNK1MKNK2RCE1
SCHEMBL6539699 0.85 HPGD (0.43) PPARDRCE1CNR1ALDH1A1MEN1
SCHEMBL6228805 0.85 MKNK1 (0.50) PPARDMKNK1MKNK2RCE1TAAR1
SCHEMBL6277754 0.84 PPARD (0.43) PPARDRCE1CNR1TAAR1MTNR1A
SCHEMBL6539472 0.83 HRH3 (0.38) PPARDMKNK1MKNK2RCE1CNR1
SCHEMBL6538954 0.83 PPARD (0.38) PPARDMKNK1MKNK2RCE1CNR1
SCHEMBL6539675 0.83 MEN1 (0.51) PPARDMKNK1MKNK2KDM4EALDH1A1
SCHEMBL6256476 0.82 PPARD (0.42) PPARDMKNK1MKNK2RCE1TAAR1
SCHEMBL6256472 0.82 PPARD (0.41) PPARDMKNK1MKNK2RCE1CNR1
SCHEMBL6539668 0.81 MTNR1A (0.58) PPARDMTNR1AMTNR1BKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583749-A1 OXAZOLE DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASE Astellas Pharma Inc. (JP) 2005-10-12 EP disclosed
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed
WO-2004065374-A1 OXAZOLE DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASE ASTELLAS PHARMA INC. (JP) 2004-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 PPARD 1747/4885MKNK1 3874/4885MKNK2 3471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.